Status:
ACTIVE_NOT_RECRUITING
The Brain Health Champion Study
Lead Sponsor:
Brigham and Women's Hospital
Conditions:
Mild Cognitive Impairment
Dementia, Mild
Eligibility:
All Genders
60-79 years
Phase:
NA
Brief Summary
6-month, randomized, controlled investigation measuring the effect of increased clinical contact and personalization compared to standard physician counseling on adherence to consensus-based, brain he...
Detailed Description
This is a 6-month, randomized, controlled investigation measuring the effect of increased clinical contact and personalized recommendations from a health coach, compared to standard physician counseli...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Be age 60 to 79
- Existing patient at Brigham Health system with at least one prior visit with providers and plans to establish/continue longitudinal care
- Be sufficiently fluent in the English language to understand instructions and perform the cognitive and functional tests
- For neurology participants only: Have a diagnosis of Subjective Cognitive Disorder (SCD) (MMSE guideline 27-30), Mild Cognitive Impairment (MCI) due to Alzheimer disease (AD), cerebrovascular disease (CVD), or mixed-type AD/CVD (MMSE guideline 24-30), or mild dementia due to AD, CVD, or mixed-AD/CVD (MMSE guideline 20-30). In some cases, based on the clinical judgment of the treating neurologist, we may enroll a patient who falls outside of these guidelines or whose diagnosis and overall level of functioning does not perfectly correlate to their MMSE score.
- For primary care participants only: Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) dementia risk score of ≥ 6, or score of 5 plus one of the following: a history of ADRD in a first-degree relative, or type II diabetes or "pre-diabetes" spectrum (A1C level ≥ 5.7)
- Exclusion criteria:
- Be enrolled in another health behavior or non-pharmacologic intervention for a neurocognitive disorder
- Be unable to or unwilling to carry out regular physical exercise, multiple times weekly.
- Be not recommended to participate by their Internist/Primary Care Provider due to health-related concerns.
Exclusion
Key Trial Info
Start Date :
May 8 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT03772977
Start Date
May 8 2017
End Date
June 1 2026
Last Update
November 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital, Department of Neurology
Boston, Massachusetts, United States, 02115